B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 47.74 CNY -1.59%
Market Cap: 20B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Betta Pharmaceuticals Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Betta Pharmaceuticals Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Betta Pharmaceuticals Co Ltd
SZSE:300558
Interest Income Expense
-ÂĄ48.7m
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
ÂĄ1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
ÂĄ149.9m
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
ÂĄ538m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
26%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
ÂĄ1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-7%
CAGR 10-Years
37%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Interest Income Expense
-ÂĄ20.1m
CAGR 3-Years
-107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Betta Pharmaceuticals Co Ltd's Interest Income Expense?
Interest Income Expense
-48.7m CNY

Based on the financial report for Jun 30, 2024, Betta Pharmaceuticals Co Ltd's Interest Income Expense amounts to -48.7m CNY.

What is Betta Pharmaceuticals Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-23%

Over the last year, the Interest Income Expense growth was 78%.

Back to Top